Davos WEF 2018: Sun Pharma Chairman Says U.S. FDA Scrutiny Will Lead To Better Products
Signage for Sun Pharmaceutical Industries Ltd. is displayed outside the company’s headquarters in Mumbai, India. (Photographer: Kuni Takahashi/Bloomberg)

Davos WEF 2018: Sun Pharma Chairman Says U.S. FDA Scrutiny Will Lead To Better Products

The Indian pharmaceutical industry is upgrading its operations in response to tighter regulations and increased scrutiny from drug regulators. And that will lead to better, more competitive product...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.